Skip to main content

Highlights

  1. 1
    The Journal of investigative dermatology · 2021
    PMID: 33549605PMCID: PMC8830938DOISenior author19 citations
  2. 2
    Pigment cell & melanoma research · 2024
    PMID: 38844435PMCID: PMC11479823DOISenior author7 citations
  3. 3
    Cell reports · 2022
    PMID: 36170819PMCID: PMC9549417DOISenior author9 citations

Publications

81 publications

Active

5 grants
  • PI
    Mechanisms of cAMP-dependent regulation of melanosome pH
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2021–2031· 2 renewals
    R01AR077664-06
  • PI
    Evaluation of Vitamin C in melanocytes
    L'Oreal USA · 2023–2028Contract
    SRA 233593-03
  • PI
    Examination of sAC inhibitors as a method to treat oculocutaneous albinism
    Vision of Children Foundation · 2026–2027
    VCF 253766-01
  • MPI
    Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1
    CTSC Cost Share · 2022–2027
    UL1TR002384-06
  • PI
    Development of in-tissue assessment of melanin synthesis to test OCA therapeutics
    National organization for albinism and hypopigmentation · 2026–2027
    NOAH 262096-01
Completed grants (11)
  • PI
    The PanAmerican Society for Pigment Cell Research (PASPCR) 25th annual conference entitled "Where pigment cell research never sleeps"
    National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2024–2025
    R13AR084871-01
  • PI
    Development of soluble adenylyl cyclase inhibitors to improve ocular pigmentation.
    National organization for albinism and hypopigmentation · 2023–2025
    NOAH 231391-02
  • KP
    Metabolic profiling of melanosome and global cellular metabolism in melanoma
    Dermatology Foundation · 2023–2024
    DF 227417-01
  • PI
    Examination of RAMBA Ability to Block Acne Pathogenic Gene Expression in Human Keratinocytes
    Hoth Therapeutics, Inc. · 2019–2021BioPharma Alliance
    HTI 202399-02
  • PI
    Mechanism of action of Crisaborole in human keratinocytes
    Pfizer Inc. · 2019–2021Contract
    51756601
  • MPI
    Uncovering the role of m6A in the melanocyte response to ultraviolet light
    National Cancer Institute · 2018–2020
    R21CA224391-02
  • Co-I
    Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
    National Cancer Institute · 2017–2019 · via YouV Labs
    HHSN261201700005C
  • PI
    Novel cAMP Signaling Pathway Regulates Melanosome pH and Pigmentation
    American Skin Association, Inc. · 2018–2019
    ASA 181188-01
  • PI
    Vitamin C as a novel therapeutic for melanoma
    Melanoma Research Foundation · 2018–2019
    MRF 184310-01
  • PI
    Establish the Relevant PDE4- and PDE7-sensitive cAMP Microdomains in Psoriasis Pathogenesis.
    Celgene Corporation · 2017–2018Contract
    Celgene SRA
  • PI
    cAMP signaling in melanoma pathogenesis: Evidence for multiple microdomains playi
    NCI · 2011–2016 · via NIH RePORTER
    K08CA160657-05

Clinical research

3 studies

Active

2 studies
  • PI
    Vitamin D deficiency and its association with allergic contact dermatitis: a retrospective cohort analysis
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Contact Dermatitis Patch Test Database Protocol; Weill Cornell Dermatology Contact Dermatitis and Patch Testing Unit in collaboration with the North American Contact Dermatitis Group
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
Completed & closed trials (1)
  • PI
    Type IV Hypersensitivity Patch Testing in a Cohort of 55 Patients with a History of Cancer: A Retrospective Chart Review Study
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)

Available technologies

News mentions

  • Discovery Could Lead to Drug Therapy for Hypopigmentation Conditions
    July 14, 2026

    An NSAID-related compound called ampyrone appears to safely boost production of the pigment melanin in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators.

  • Awards and Honors: June 2023
    June 30, 2023

    Awards, honors and achievements for the month of June.

  • Novel Technique Reveals Surprising New Way to Suppress Tumor Cells
    September 27, 2022

    By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced. The work, published Sept. 27 in Cell Reports, reveals a new aspect of tumor cell biology, and points to a promising strategy for treating many types of cancer. Cells use the small molecule cyclic AMP (cAMP) to trigger different effects largely depending on the proteins it activates. For example, past studies have shown that cAMP can either activate or suppress tumor growth under different circumstances. “Most people have studied cAMP by studying the effector proteins that [mediate its activity], or they've looked at the [enzymes that] inactivate it,” said co-senior author Dr. Jonathan H. Zippin, vice chair of research and an associate professor of dermatology and pharmacology at Weill Cornell Medicine, director of dermatology precision medicine at the Englander Institute for Precision Medicine, and a dermatologist at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Taha Merghoub, deputy director of the Sandra and Edward Meyer Cancer Center, the Margaret and Herman Sokol Professor of Oncology Research and a professor of pharmacology, as well as Dr. Elena Piskounova, an assistant professor of cell biology in dermatology, are also co-senior authors on the study. Instead of turning cAMP signaling on or off across the entire cell, as previous studies had done, Dr. Marek Drozdz, a postdoctoral associate in Dr. Zippin’s lab, wanted to activate cAMP in specific subcellular compartments. Two enzymes can produce cAMP in a cell: one bound to the plasma membrane and one that’s soluble. “We focused on the soluble one, because this source of cAMP could be targeted to different compartments within the cell, and then evoke a little pocket of cAMP signaling in each compartment,” said Dr. Drozdz, who is the lead author on the paper. To do…

  • Prestigious Awards and Prizes Presented to Faculty and Students
    July 8, 2019

    Weill Cornell Medicine faculty members honored with annual awards at Convocation and Commencement for their exemplary achievements.

External relationships

Other Interest

Amorepacific Corporation · Hoth Therapeutics, Inc. · Mitsubishi Tanabe Pharma Development America, Inc.